Berkley W R Corp Purchases 534,533 Shares of GP-Act III Acquisition Corp. $GPAT

Berkley W R Corp increased its position in shares of GP-Act III Acquisition Corp. (NASDAQ:GPAT) by 171.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 846,823 shares of the company’s stock after buying an additional 534,533 shares during the period. Berkley W R Corp’s holdings in GP-Act III Acquisition were worth $9,180,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Cannon Global Investment Management LLC lifted its stake in GP-Act III Acquisition by 15.2% in the first quarter. Cannon Global Investment Management LLC now owns 16,700 shares of the company’s stock worth $181,000 after acquiring an additional 2,200 shares during the period. Lineage Point Capital LP bought a new stake in shares of GP-Act III Acquisition in the 4th quarter valued at about $695,000. Meteora Capital LLC raised its holdings in shares of GP-Act III Acquisition by 62.8% in the 4th quarter. Meteora Capital LLC now owns 408,719 shares of the company’s stock valued at $4,369,000 after purchasing an additional 157,689 shares in the last quarter. Verition Fund Management LLC lifted its position in shares of GP-Act III Acquisition by 0.7% in the 4th quarter. Verition Fund Management LLC now owns 229,124 shares of the company’s stock worth $2,452,000 after purchasing an additional 1,500 shares during the period. Finally, Westchester Capital Management LLC lifted its position in shares of GP-Act III Acquisition by 22.5% in the 4th quarter. Westchester Capital Management LLC now owns 1,360,852 shares of the company’s stock worth $14,561,000 after purchasing an additional 250,000 shares during the period.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

GP-Act III Acquisition Price Performance

NASDAQ:GPAT opened at $11.05 on Monday. GP-Act III Acquisition Corp. has a twelve month low of $10.50 and a twelve month high of $12.00. The company’s 50 day moving average is $10.95 and its two-hundred day moving average is $10.85.

GP-Act III Acquisition (NASDAQ:GPAT) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.06 earnings per share for the quarter.

About GP-Act III Acquisition

GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.